FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023961731> ?p ?o ?g. }

• W2023961731 endingPage "36" @default.
• W2023961731 startingPage "32" @default.
• W2023961731 abstract "Phosphodiesterase 5 (PDE5) inhibitors have modest nitrate-like hemodynamic effects, lowering wedge pressure, pulmonary artery pressure, and systolic and diastolic arterial pressure. At rest, decreases in arterial pressure averaging 9/8 mm Hg may increase to 12/5 mm Hg as a result of the vasodilatory response, but no clinical adverse effects have been reported. On the background of increased vasoconstriction related to elevation of angiotensin II, a greater decrease may occur and be relevant to cardiovascular therapy, particularly if angiotensin II antagonists are coprescribed. Exercise studies in patients with ischemia identified no adverse event potential for sildenafil, vardenafil, and tadalafil. Another study showed sildenafil had an anti-ischemic effect, increasing time to limiting angina. Evidence supports the safety of these agents in patients with chronic stable coronary artery disease (CAD). With accumulating evidence of benefits on endothelial function and clinical improvements in pulmonary hypertension and heart failure, the hemodynamic and exercise effects of PDE5 inhibitors suggest an important therapeutic cardiovascular role, reinforcing their safety in the patient with CAD and erectile dysfunction. Phosphodiesterase 5 (PDE5) inhibitors have modest nitrate-like hemodynamic effects, lowering wedge pressure, pulmonary artery pressure, and systolic and diastolic arterial pressure. At rest, decreases in arterial pressure averaging 9/8 mm Hg may increase to 12/5 mm Hg as a result of the vasodilatory response, but no clinical adverse effects have been reported. On the background of increased vasoconstriction related to elevation of angiotensin II, a greater decrease may occur and be relevant to cardiovascular therapy, particularly if angiotensin II antagonists are coprescribed. Exercise studies in patients with ischemia identified no adverse event potential for sildenafil, vardenafil, and tadalafil. Another study showed sildenafil had an anti-ischemic effect, increasing time to limiting angina. Evidence supports the safety of these agents in patients with chronic stable coronary artery disease (CAD). With accumulating evidence of benefits on endothelial function and clinical improvements in pulmonary hypertension and heart failure, the hemodynamic and exercise effects of PDE5 inhibitors suggest an important therapeutic cardiovascular role, reinforcing their safety in the patient with CAD and erectile dysfunction." @default.
• W2023961731 created "2016-06-24" @default.
• W2023961731 creator A5060925457 @default.
• W2023961731 date "2005-12-01" @default.
• W2023961731 modified "2023-09-28" @default.
• W2023961731 title "Hemodynamic and Exercise Effects of Phosphodiesterase 5 Inhibitors" @default.
• W2023961731 cites W1971406218 @default.
• W2023961731 cites W1975319833 @default.
• W2023961731 cites W1981902060 @default.
• W2023961731 cites W2006654512 @default.
• W2023961731 cites W2012177749 @default.
• W2023961731 cites W2022209234 @default.
• W2023961731 cites W2030099266 @default.
• W2023961731 cites W2070010226 @default.
• W2023961731 cites W2072803364 @default.
• W2023961731 cites W2074646239 @default.
• W2023961731 cites W2103058477 @default.
• W2023961731 cites W2111745105 @default.
• W2023961731 cites W2114544175 @default.
• W2023961731 cites W2118905420 @default.
• W2023961731 cites W2125142347 @default.
• W2023961731 cites W2145935159 @default.
• W2023961731 cites W2148565257 @default.
• W2023961731 cites W2218378049 @default.
• W2023961731 cites W2470584014 @default.
• W2023961731 doi "https://doi.org/10.1016/j.amjcard.2005.07.009" @default.
• W2023961731 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16387564" @default.
• W2023961731 hasPublicationYear "2005" @default.
• W2023961731 type Work @default.
• W2023961731 sameAs 2023961731 @default.
• W2023961731 citedByCount "20" @default.
• W2023961731 countsByYear W20239617312012 @default.
• W2023961731 countsByYear W20239617312014 @default.
• W2023961731 countsByYear W20239617312015 @default.
• W2023961731 countsByYear W20239617312016 @default.
• W2023961731 countsByYear W20239617312018 @default.
• W2023961731 countsByYear W20239617312021 @default.
• W2023961731 crossrefType "journal-article" @default.
• W2023961731 hasAuthorship W2023961731A5060925457 @default.
• W2023961731 hasConcept C120770815 @default.
• W2023961731 hasConcept C126322002 @default.
• W2023961731 hasConcept C146556889 @default.
• W2023961731 hasConcept C164705383 @default.
• W2023961731 hasConcept C178853913 @default.
• W2023961731 hasConcept C2776768464 @default.
• W2023961731 hasConcept C2778198053 @default.
• W2023961731 hasConcept C2779961880 @default.
• W2023961731 hasConcept C2780940725 @default.
• W2023961731 hasConcept C71924100 @default.
• W2023961731 hasConcept C84393581 @default.
• W2023961731 hasConceptScore W2023961731C120770815 @default.
• W2023961731 hasConceptScore W2023961731C126322002 @default.
• W2023961731 hasConceptScore W2023961731C146556889 @default.
• W2023961731 hasConceptScore W2023961731C164705383 @default.
• W2023961731 hasConceptScore W2023961731C178853913 @default.
• W2023961731 hasConceptScore W2023961731C2776768464 @default.
• W2023961731 hasConceptScore W2023961731C2778198053 @default.
• W2023961731 hasConceptScore W2023961731C2779961880 @default.
• W2023961731 hasConceptScore W2023961731C2780940725 @default.
• W2023961731 hasConceptScore W2023961731C71924100 @default.
• W2023961731 hasConceptScore W2023961731C84393581 @default.
• W2023961731 hasIssue "12" @default.
• W2023961731 hasLocation W20239617311 @default.
• W2023961731 hasLocation W20239617312 @default.
• W2023961731 hasOpenAccess W2023961731 @default.
• W2023961731 hasPrimaryLocation W20239617311 @default.
• W2023961731 hasRelatedWork W133119128 @default.
• W2023961731 hasRelatedWork W1515836815 @default.
• W2023961731 hasRelatedWork W1967563212 @default.
• W2023961731 hasRelatedWork W2010738716 @default.
• W2023961731 hasRelatedWork W2059923869 @default.
• W2023961731 hasRelatedWork W2063724005 @default.
• W2023961731 hasRelatedWork W2372908060 @default.
• W2023961731 hasRelatedWork W3003242440 @default.
• W2023961731 hasRelatedWork W3082514971 @default.
• W2023961731 hasRelatedWork W4385716628 @default.
• W2023961731 hasVolume "96" @default.
• W2023961731 isParatext "false" @default.
• W2023961731 isRetracted "false" @default.
• W2023961731 magId "2023961731" @default.
• W2023961731 workType "article" @default.